# Ypsomed invests over CHF 100 million in Solothurn site expansion

Ypsomed will invest over CHF 100 million over the next four years to expand autoinjector production capacities at its Solothurn site.

- Type: Investment
- Announced: 2024-03-27
- Where: Solothurn, Switzerland, Switzerland
- Value: $110.0M (100.0M CHF)
- Status: announced
- Products: autoinjectors
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ypsomed](https://endata.com/companies/9625.md)

## Sources

- [ypsomed.com](https://www.ypsomed.com/en/investors/ad-hoc-announcements/ad-hoc-detail-page/ypsomed-sells-its-pen-needle-and-bgm-business-to-mtd-and-invests-in-the-expansion-of-its-solothurn-site), 2024-03-27: "Ypsomed will invest over CHF 100 million over the next four years in the expansion of capacities for autoinjectors at the Solothurn site."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.